DDIT4 and ovarian carcinoma: The purpose of this study was to evaluate the association between REDD1 expression in different locations and clinical pathological factors (including age, pathology diagnosis, tumor grade, disease stage, ascites, serum CA125 level, clinical response to chemotherapy) as well as overall survival(OS)and disease-free survival (DFS) for ovarian cancer patients.